| Dexamethasone 4 mg/m2 (n = 68) | Prednisone 40 mg/m2 (n = 66) | Total (n = 134) | OR | 95% CI | P-value | |||
| n | % | n | % | n | % |
|
|
|
Induction treatment |
|
|
|
|
|
|
|
|
|
Complete remission | 48 | 70.6 | 52 | 78.8 | 100 | 74.6 |
|
|
|
Induction failures | 20 | 29.4 | 14 | 21.2 | 34 | 25.4 | 0.65 | 0.29 - 1.42a | 0.271 |
Abandonment | 8 | 11.7 | 7 | 10.6 | 15 | 11.2 | 0.81 | 0.27 - 2.39a | 0.701 |
Death | 11 | 16.2 | 4 | 6.1 | 15 | 11.2 | 0.34 | 0.10 - 1.13a | 0.061 |
Resistant disease | 1 | 1.5 | 3 | 4.5 | 4 | 3.0 | 2.77 | 0.28 - 27.54a | 0.622 |
Overall events |
|
|
|
|
|
|
|
|
|
Continuous CR | 31 | 45.6 | 35 | 53.1 | 66 | 49.3 |
|
|
|
Treatment failures | 37 | 54.4 | 31 | 46.9 | 68 | 50.7 | 0.74 | 0.38 - 1.46b | 0.391 |
Abandonment | 16 | 23.5 | 13 | 19.7 | 29 | 21.6 | 0.72 | 0.30 - 1.73b | 0.461 |
Death | 13 | 19.2 | 9 | 13.6 | 22 | 16.4 | 0.61 | 0.23 - 1.63b | 0.321 |
Leukemic event | 8 | 11.7 | 9 | 13.6 | 17 | 12.7 | 0.99 | 0.34 - 2.90b | 0.991 |